Brazilian Guidelines for the pharmacological treatment of patients hospitalized with COVID-19: Joint guideline of Associação Brasileira de Medicina de Emergência, Associação de Medicina Intensiva Brasileira, Associação Médica Brasileira, Sociedade Brasileira de Angiologia e Cirurgia Vascular, Sociedade Brasileira de Infectologia, Sociedade Brasileira de Pneumologia e Tisiologia, Sociedade Brasileira de Reumatologia.
- DOI
- 10.5935/0103-507x.20220001-pt
- Published
- 2022 Jan-Mar
- Container
- Revista Brasileira de terapia intensiva
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.5935/0103-507x.20220001-pt,
title = {Brazilian Guidelines for the pharmacological treatment of patients hospitalized with COVID-19: Joint guideline of Associação Brasileira de Medicina de Emergência, Associação de Medicina Intensiva Brasileira, Associação Médica Brasileira, Sociedade Brasileira de Angiologia e Cirurgia Vascular, Sociedade Brasileira de Infectologia, Sociedade Brasileira de Pneumologia e Tisiologia, Sociedade Brasileira de Reumatologia.},
author = {Falavigna M and Stein C and Amaral JLGD and Azevedo LCP and Belli KC and Colpani V and Cunha CAD and Dal-Pizzol F and Dias MBS and Ferreira JC and Freitas APDR and Gräf DD and Guimarães HP and Lobo SMA and Monteiro JT and Nunes MS and Oliveira MS and Prado CCL and Santos VCC and Silva RMD and Sobreira ML and Veiga VC and Vidal ÁT and Xavier RM and Zavascki AP and Machado FR and Carvalho CRR},
year = {2022},
journal = {Revista Brasileira de terapia intensiva},
doi = {10.5935/0103-507x.20220001-pt},
url = {https://doi.org/10.5935/0103-507x.20220001-pt}
}RIS
TY - JOUR TI - Brazilian Guidelines for the pharmacological treatment of patients hospitalized with COVID-19: Joint guideline of Associação Brasileira de Medicina de Emergência, Associação de Medicina Intensiva Brasileira, Associação Médica Brasileira, Sociedade Brasileira de Angiologia e Cirurgia Vascular, Sociedade Brasileira de Infectologia, Sociedade Brasileira de Pneumologia e Tisiologia, Sociedade Brasileira de Reumatologia. AU - Falavigna M AU - Stein C AU - Amaral JLGD AU - Azevedo LCP AU - Belli KC AU - Colpani V AU - Cunha CAD AU - Dal-Pizzol F AU - Dias MBS AU - Ferreira JC AU - Freitas APDR AU - Gräf DD AU - Guimarães HP AU - Lobo SMA AU - Monteiro JT AU - Nunes MS AU - Oliveira MS AU - Prado CCL AU - Santos VCC AU - Silva RMD AU - Sobreira ML AU - Veiga VC AU - Vidal ÁT AU - Xavier RM AU - Zavascki AP AU - Machado FR AU - Carvalho CRR PY - 2022 JO - Revista Brasileira de terapia intensiva DO - 10.5935/0103-507x.20220001-pt UR - https://doi.org/10.5935/0103-507x.20220001-pt ER -
APA
M, F., C, S., JLGD, A., LCP, A., KC, B., V, C., CAD, C., F, D., MBS, D., JC, F., APDR, F., DD, G., HP, G., SMA, L., JT, M., MS, N., MS, O., CCL, P., VCC, S., RMD, S., ML, S., VC, V., ÁT, V., RM, X., AP, Z., FR, M., & CRR, C. (2022). Brazilian Guidelines for the pharmacological treatment of patients hospitalized with COVID-19: Joint guideline of Associação Brasileira de Medicina de Emergência, Associação de Medicina Intensiva Brasileira, Associação Médica Brasileira, Sociedade Brasileira de Angiologia e Cirurgia Vascular, Sociedade Brasileira de Infectologia, Sociedade Brasileira de Pneumologia e Tisiologia, Sociedade Brasileira de Reumatologia.. Revista Brasileira de terapia intensiva. https://doi.org/10.5935/0103-507x.20220001-pt